VitamFero, a company developing novel anti-infective (notably anti-parasitics) prophylactic applications in animal health, has just secured a new capital increase in the amount of €2.7 million with GO CAPITAL (through the Ouest Ventures II fund), Pradeyrol Développement and Business Angels affiliated with Val de France Angels
Voluntis, a company pioneering therapeutic companion software, today announced the completion of its Series D financing round. With a total of €20.75 million ($29 million), this fund raising is one of the largest rounds of investment in the m-health sector this year. The round was co- led by Bpifrance Large Venture and international venture capital firm Innovation Capital
Axess Vision Technology who develops single use instruments for endoscopy, limiting contamination risk, has closed a €3.5 Million second round of financing.